Treatment for Hemorrhoids

Treatment of Chronic Venous Disease

5/8/2023

Diosmin + Hesperidin (Daflon 1000) A Natural Health Product

Diosmin + Hesperdin (Daflon 1000) is an over-the-counter oral treatment for hemorrhoids (almoranas). It is a natural health product that helps relieve almoranas symptoms. Almoranas symptoms appear when veins in the rectum or butt area are disrupted.1

How is it “natural?”

Diosmin + Hesperidin (Daflon 1000) is natural in origin, as it all begins with immature oranges. Immature here meaning the oranges are not fully formed. Small, immature orange fruits (10 mm to 20 mm in diameter) are harvested when they fall from orange trees in plantations at the end of the flowering period.2 But it’s not the delightful, round and juicy orange you usually buy at the markets that go into Diosmin + Hesperidin (Daflon 1000) — every single orange blossom produces four or five oranges, but only one will fully develop into an orange like those we enjoy eating. The other three or four oranges from the blossom never fully mature; those are the types of oranges that are important in the process of creating Diosmin + Hesperidin (Daflon 1000).2

Once harvested, the immature oranges go through a process of drying and grinding: after being left in the sun to dry in the open air for two weeks, they are ground down to a powder which will be the starting material used to extract the active ingredients for Diosmin + Hesperdin (Daflon 1000).2

immature oranges for daflon

 

Why oranges?

The small fruits from the orange blossom that don’t mature into oranges are bursting with a flavonoid called hesperidin.

A flavonoid, also called bioflavonoid, is a fancy word for a class of compounds that naturally exist within many fruits and vegetables and other products made from plants. Hesperidin is one of these: a naturally occurring plant chemical most found in citrus fruits.2

Once the flavonoids have been extracted, it goes through a process to further refine and purify them in order to achieve extremely high and powerful concentrates. It reaches a state called micronized purified flavonoid fraction, which is key to Diosmin + Hesperidin (Daflon 1000) benefits.2

Micronized Purified Flavonoid Fraction (MPFF)

Micronized purified flavonoid fraction3 is what sets Diosmin + Hesperidin (Daflon 1000) apart to provide those experiencing hemorrhoids or almoranas symptoms with effective results. Our experts have found that making flavonoid fraction particles smaller makes them more bioavailable, meaning they can be absorbed more easily by the body, ensuring you get as many benefits as possible with every single pill. 

Before the micronization process, the purified flavonoid fraction is about 42 microns (μm) in size. To give you an idea, the diameter of a human hair varies between 17 to 181 μm. The particles are then made to collide with each other at unbelievable speeds through the use of air jets, breaking them into much smaller particles of less than 2 μm in size, smaller than some bacteria!4

daflon micronization

This means every Diosmin + Hesperdin (Daflon 1000) pill is jam packed with the goodness that immature oranges can naturally provide us, and have been prepared to ensure you get the most out of it—exactly what you want when treating hemorrhoids or almoranas.

No matter where you are on your health journey, it’s always a good feeling to know that an easy-to-manage treatment that works well for you is also a natural health product.

References

  1. Mayo Clinic. Almoranas. Retrieved October 13, 2020, from www.mayoclinic.org/diseases-conditions/hemorrhoids/ symptoms-causes/syc-20360268
  2. https://www.daflon.com.hk/composition-production/?succes=1607677035
  3. Takase S et al. Eur J Vasc Endovasc Surg. 2004;28:484-493; Paysant J, Intl. Angiol 2008, Vol 27, No. 1, 81-85(2008); Bouskela Eur J Vasc Endovasc Sur 2018, 10=-9; Barbe M.Amiel R. Phlebology Suppl. 41-44(1992); Zupanets I. et al. Asian J Pharmaceutical and Clinical Research 2018; 10:504-508.
  4. Takase S et al. Eur J Vasc Endovasc Surg. 2004;28:484-493; Paysant J, Intl. Angiol 2008, Vol 27, No. 1, 81-85(2008); Bouskela Eur J Vasc Endovasc Sur 2018, 10=-9; Barbe M.Amiel R. Phlebology Suppl. 41-44(1992); Zupanets I. et al. Asian J Pharmaceutical and Clinical Research 2018; 10:504-508.

2024